title: Need for awareness about interaction between nonprescription intranasal corticosteroids and pharmacokinetic enhancers.
authors.affiliation: Mountain States Health AllianceJohnson City, TNnelsonbr@etsu.edu.
authors.forename: Brooklyn
authors.initials: B
authors.lastname: Nelson
authors.affiliation: Department of Pharmacy PracticeBill Gatton College of PharmacyEast Tennessee State University (ETSU)Johnson City, TN.
authors.forename: David
authors.initials: D
authors.lastname: Cluck
authors.affiliation: Department of Pharmacy PracticeBill Gatton College of PharmacyEast Tennessee State University (ETSU)Johnson City, TN.
authors.forename: Katelyn
authors.initials: K
authors.lastname: Alexander
authors.affiliation: Center of ExcellenceETSU Physicians and AssociatesJohnson City, TN.
authors.forename: Roxanne F
authors.initials: RF
authors.lastname: Underwood
authors.affiliation: Department of Pharmacy PracticeBill Gatton College of PharmacyETSU.
authors.forename: L Brian
authors.initials: LB
authors.lastname: Cross
mesh_terms: D000281:Administration, Intranasal; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active; D004347:Drug Interactions; D006801:Humans; D004366:Nonprescription Drugs; D010599:Pharmacokinetics; D011480:Protease Inhibitors / Q000493:pharmacokinetics
chemical_list: D000305:Adrenal Cortex Hormones; D004366:Nonprescription Drugs; D011480:Protease Inhibitors